Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hydrogel-based Drug Delivery Device Market Research Report 2024
Global Hydrogel-based Drug Delivery Device Market Research Report 2024
Industry: Medical Devices & Consumables
Published Date: 2024-07-07
Pages: 109 Pages
Report ld: 3233761
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Hydrogel-based Drug Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Hydrogel-based Drug Delivery Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Hydrogel-based Drug Delivery Device include AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Hydrogel-based Drug Delivery Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hydrogel-based Drug Delivery Device.
The Hydrogel-based Drug Delivery Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Hydrogel-based Drug Delivery Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hydrogel-based Drug Delivery Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AstraZeneca Plc.
Columbia Laboratories Inc.
Mylan
Teva Pharmaceuticals USA Inc.
Blairex Laboratories Inc.
ARx LLC.
Endo International plc
BioDelivery Sciences International Inc.
Indivior PLC
GSK Plc
Pfizer Inc.
Aquestive Therapeutics Inc.
ZIM LABORATORIES LIMITED
IntelGenx Corp.
NEXGEL
Bliss GVS Pharma Ltd.
Teika Pharmaceutical Co. Ltd.
Medherant Limited
Galderma
Johnson & Johnson
Bausch and Lomb
Ferring B.V
Segment by Type
Oral
Buccal
Rectal
Vaginal
Other
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hydrogel-based Drug Delivery Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hydrogel-based Drug Delivery Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Hydrogel-based Drug Delivery Device Market Overview
1.1 Product Definition
1.2 Hydrogel-based Drug Delivery Device by Type
1.2.1 Global Hydrogel-based Drug Delivery Device Market Value Comparison by Type (2024-2030)
1.2.2 Oral
1.2.3 Buccal
1.2.4 Rectal
1.2.5 Vaginal
1.2.6 Other
1.3 Hydrogel-based Drug Delivery Device by Application
1.3.1 Global Hydrogel-based Drug Delivery Device Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Hydrogel-based Drug Delivery Device Market Size Estimates and Forecasts
1.4.1 Global Hydrogel-based Drug Delivery Device Revenue 2019-2030
1.4.2 Global Hydrogel-based Drug Delivery Device Sales 2019-2030
1.4.3 Global Hydrogel-based Drug Delivery Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Hydrogel-based Drug Delivery Device Market Competition by Manufacturers
2.1 Global Hydrogel-based Drug Delivery Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Hydrogel-based Drug Delivery Device Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Hydrogel-based Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Product Type & Application
2.7 Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Date of Enter into This Industry
2.8 Global Hydrogel-based Drug Delivery Device Market Competitive Situation and Trends
2.8.1 Global Hydrogel-based Drug Delivery Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hydrogel-based Drug Delivery Device Players Market Share by Revenue
2.8.3 Global Hydrogel-based Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hydrogel-based Drug Delivery Device Market Scenario by Region
3.1 Global Hydrogel-based Drug Delivery Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Hydrogel-based Drug Delivery Device Sales by Region: 2019-2030
3.2.1 Global Hydrogel-based Drug Delivery Device Sales by Region: 2019-2024
3.2.2 Global Hydrogel-based Drug Delivery Device Sales by Region: 2025-2030
3.3 Global Hydrogel-based Drug Delivery Device Revenue by Region: 2019-2030
3.3.1 Global Hydrogel-based Drug Delivery Device Revenue by Region: 2019-2024
3.3.2 Global Hydrogel-based Drug Delivery Device Revenue by Region: 2025-2030
3.4 North America Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.4.1 North America Hydrogel-based Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Hydrogel-based Drug Delivery Device Sales by Country (2019-2030)
3.4.3 North America Hydrogel-based Drug Delivery Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.5.1 Europe Hydrogel-based Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Hydrogel-based Drug Delivery Device Sales by Country (2019-2030)
3.5.3 Europe Hydrogel-based Drug Delivery Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hydrogel-based Drug Delivery Device Market Facts & Figures by Region
3.6.1 Asia Pacific Hydrogel-based Drug Delivery Device Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Hydrogel-based Drug Delivery Device Sales by Region (2019-2030)
3.6.3 Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.7.1 Latin America Hydrogel-based Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Hydrogel-based Drug Delivery Device Sales by Country (2019-2030)
3.7.3 Latin America Hydrogel-based Drug Delivery Device Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hydrogel-based Drug Delivery Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Hydrogel-based Drug Delivery Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Hydrogel-based Drug Delivery Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hydrogel-based Drug Delivery Device Sales by Type (2019-2030)
4.1.1 Global Hydrogel-based Drug Delivery Device Sales by Type (2019-2024)
4.1.2 Global Hydrogel-based Drug Delivery Device Sales by Type (2025-2030)
4.1.3 Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2030)
4.2 Global Hydrogel-based Drug Delivery Device Revenue by Type (2019-2030)
4.2.1 Global Hydrogel-based Drug Delivery Device Revenue by Type (2019-2024)
4.2.2 Global Hydrogel-based Drug Delivery Device Revenue by Type (2025-2030)
4.2.3 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2030)
4.3 Global Hydrogel-based Drug Delivery Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Hydrogel-based Drug Delivery Device Sales by Application (2019-2030)
5.1.1 Global Hydrogel-based Drug Delivery Device Sales by Application (2019-2024)
5.1.2 Global Hydrogel-based Drug Delivery Device Sales by Application (2025-2030)
5.1.3 Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2030)
5.2 Global Hydrogel-based Drug Delivery Device Revenue by Application (2019-2030)
5.2.1 Global Hydrogel-based Drug Delivery Device Revenue by Application (2019-2024)
5.2.2 Global Hydrogel-based Drug Delivery Device Revenue by Application (2025-2030)
5.2.3 Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2030)
5.3 Global Hydrogel-based Drug Delivery Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 AstraZeneca Plc.
6.1.1 AstraZeneca Plc. Company Information
6.1.2 AstraZeneca Plc. Description and Business Overview
6.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Portfolio
6.1.5 AstraZeneca Plc. Recent Developments/Updates
6.2 Columbia Laboratories Inc.
6.2.1 Columbia Laboratories Inc. Company Information
6.2.2 Columbia Laboratories Inc. Description and Business Overview
6.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.2.5 Columbia Laboratories Inc. Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mylan Hydrogel-based Drug Delivery Device Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Teva Pharmaceuticals USA Inc.
6.4.1 Teva Pharmaceuticals USA Inc. Company Information
6.4.2 Teva Pharmaceuticals USA Inc. Description and Business Overview
6.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.4.5 Teva Pharmaceuticals USA Inc. Recent Developments/Updates
6.5 Blairex Laboratories Inc.
6.5.1 Blairex Laboratories Inc. Company Information
6.5.2 Blairex Laboratories Inc. Description and Business Overview
6.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.5.5 Blairex Laboratories Inc. Recent Developments/Updates
6.6 ARx LLC.
6.6.1 ARx LLC. Company Information
6.6.2 ARx LLC. Description and Business Overview
6.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Product Portfolio
6.6.5 ARx LLC. Recent Developments/Updates
6.7 Endo International plc
6.7.1 Endo International plc Company Information
6.7.2 Endo International plc Description and Business Overview
6.7.3 Endo International plc Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Endo International plc Hydrogel-based Drug Delivery Device Product Portfolio
6.7.5 Endo International plc Recent Developments/Updates
6.8 BioDelivery Sciences International Inc.
6.8.1 BioDelivery Sciences International Inc. Company Information
6.8.2 BioDelivery Sciences International Inc. Description and Business Overview
6.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.8.5 BioDelivery Sciences International Inc. Recent Developments/Updates
6.9 Indivior PLC
6.9.1 Indivior PLC Company Information
6.9.2 Indivior PLC Description and Business Overview
6.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Product Portfolio
6.9.5 Indivior PLC Recent Developments/Updates
6.10 GSK Plc
6.10.1 GSK Plc Company Information
6.10.2 GSK Plc Description and Business Overview
6.10.3 GSK Plc Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 GSK Plc Hydrogel-based Drug Delivery Device Product Portfolio
6.10.5 GSK Plc Recent Developments/Updates
6.11 Pfizer Inc.
6.11.1 Pfizer Inc. Company Information
6.11.2 Pfizer Inc. Description and Business Overview
6.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.11.5 Pfizer Inc. Recent Developments/Updates
6.12 Aquestive Therapeutics Inc.
6.12.1 Aquestive Therapeutics Inc. Company Information
6.12.2 Aquestive Therapeutics Inc. Description and Business Overview
6.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Portfolio
6.12.5 Aquestive Therapeutics Inc. Recent Developments/Updates
6.13 ZIM LABORATORIES LIMITED
6.13.1 ZIM LABORATORIES LIMITED Company Information
6.13.2 ZIM LABORATORIES LIMITED Description and Business Overview
6.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Portfolio
6.13.5 ZIM LABORATORIES LIMITED Recent Developments/Updates
6.14 IntelGenx Corp.
6.14.1 IntelGenx Corp. Company Information
6.14.2 IntelGenx Corp. Description and Business Overview
6.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Portfolio
6.14.5 IntelGenx Corp. Recent Developments/Updates
6.15 NEXGEL
6.15.1 NEXGEL Company Information
6.15.2 NEXGEL Description and Business Overview
6.15.3 NEXGEL Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 NEXGEL Hydrogel-based Drug Delivery Device Product Portfolio
6.15.5 NEXGEL Recent Developments/Updates
6.16 Bliss GVS Pharma Ltd.
6.16.1 Bliss GVS Pharma Ltd. Company Information
6.16.2 Bliss GVS Pharma Ltd. Description and Business Overview
6.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Portfolio
6.16.5 Bliss GVS Pharma Ltd. Recent Developments/Updates
6.17 Teika Pharmaceutical Co. Ltd.
6.17.1 Teika Pharmaceutical Co. Ltd. Company Information
6.17.2 Teika Pharmaceutical Co. Ltd. Description and Business Overview
6.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Portfolio
6.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
6.18 Medherant Limited
6.18.1 Medherant Limited Company Information
6.18.2 Medherant Limited Description and Business Overview
6.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Product Portfolio
6.18.5 Medherant Limited Recent Developments/Updates
6.19 Galderma
6.19.1 Galderma Company Information
6.19.2 Galderma Description and Business Overview
6.19.3 Galderma Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Galderma Hydrogel-based Drug Delivery Device Product Portfolio
6.19.5 Galderma Recent Developments/Updates
6.20 Johnson & Johnson
6.20.1 Johnson & Johnson Company Information
6.20.2 Johnson & Johnson Description and Business Overview
6.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Product Portfolio
6.20.5 Johnson & Johnson Recent Developments/Updates
6.21 Bausch and Lomb
6.21.1 Bausch and Lomb Company Information
6.21.2 Bausch and Lomb Description and Business Overview
6.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Product Portfolio
6.21.5 Bausch and Lomb Recent Developments/Updates
6.22 Ferring B.V
6.22.1 Ferring B.V Company Information
6.22.2 Ferring B.V Description and Business Overview
6.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Sales, Revenue and Gross Margin (2019-2024)
6.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Product Portfolio
6.22.5 Ferring B.V Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hydrogel-based Drug Delivery Device Industry Chain Analysis
7.2 Hydrogel-based Drug Delivery Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hydrogel-based Drug Delivery Device Production Mode & Process
7.4 Hydrogel-based Drug Delivery Device Sales and Marketing
7.4.1 Hydrogel-based Drug Delivery Device Sales Channels
7.4.2 Hydrogel-based Drug Delivery Device Distributors
7.5 Hydrogel-based Drug Delivery Device Customers
8 Hydrogel-based Drug Delivery Device Market Dynamics
8.1 Hydrogel-based Drug Delivery Device Industry Trends
8.2 Hydrogel-based Drug Delivery Device Market Drivers
8.3 Hydrogel-based Drug Delivery Device Market Challenges
8.4 Hydrogel-based Drug Delivery Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hydrogel-based Drug Delivery Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hydrogel-based Drug Delivery Device Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Hydrogel-based Drug Delivery Device Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hydrogel-based Drug Delivery Device Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Hydrogel-based Drug Delivery Device Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hydrogel-based Drug Delivery Device Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hydrogel-based Drug Delivery Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hydrogel-based Drug Delivery Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Product Type & Application
Table 12. Global Key Manufacturers of Hydrogel-based Drug Delivery Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hydrogel-based Drug Delivery Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hydrogel-based Drug Delivery Device as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hydrogel-based Drug Delivery Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hydrogel-based Drug Delivery Device Sales by Region (2019-2024) & (K Units)
Table 18. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2019-2024)
Table 19. Global Hydrogel-based Drug Delivery Device Sales by Region (2025-2030) & (K Units)
Table 20. Global Hydrogel-based Drug Delivery Device Sales Market Share by Region (2025-2030)
Table 21. Global Hydrogel-based Drug Delivery Device Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2019-2024)
Table 23. Global Hydrogel-based Drug Delivery Device Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2025-2030)
Table 25. North America Hydrogel-based Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hydrogel-based Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 27. North America Hydrogel-based Drug Delivery Device Sales by Country (2025-2030) & (K Units)
Table 28. North America Hydrogel-based Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hydrogel-based Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hydrogel-based Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hydrogel-based Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 32. Europe Hydrogel-based Drug Delivery Device Sales by Country (2025-2030) & (K Units)
Table 33. Europe Hydrogel-based Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hydrogel-based Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hydrogel-based Drug Delivery Device Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Hydrogel-based Drug Delivery Device Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hydrogel-based Drug Delivery Device Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hydrogel-based Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hydrogel-based Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Hydrogel-based Drug Delivery Device Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Hydrogel-based Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Hydrogel-based Drug Delivery Device Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Hydrogel-based Drug Delivery Device Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Type (2019-2024)
Table 51. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Type (2025-2030)
Table 52. Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2019-2024)
Table 53. Global Hydrogel-based Drug Delivery Device Sales Market Share by Type (2025-2030)
Table 54. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2019-2024)
Table 57. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Type (2025-2030)
Table 58. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Type (2019-2024)
Table 59. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Type (2025-2030)
Table 60. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Application (2019-2024)
Table 61. Global Hydrogel-based Drug Delivery Device Sales (K Units) by Application (2025-2030)
Table 62. Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2019-2024)
Table 63. Global Hydrogel-based Drug Delivery Device Sales Market Share by Application (2025-2030)
Table 64. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hydrogel-based Drug Delivery Device Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2019-2024)
Table 67. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Application (2025-2030)
Table 68. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Application (2019-2024)
Table 69. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Application (2025-2030)
Table 70. AstraZeneca Plc. Company Information
Table 71. AstraZeneca Plc. Description and Business Overview
Table 72. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product
Table 74. AstraZeneca Plc. Recent Developments/Updates
Table 75. Columbia Laboratories Inc. Company Information
Table 76. Columbia Laboratories Inc. Description and Business Overview
Table 77. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product
Table 79. Columbia Laboratories Inc. Recent Developments/Updates
Table 80. Mylan Company Information
Table 81. Mylan Description and Business Overview
Table 82. Mylan Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Mylan Hydrogel-based Drug Delivery Device Product
Table 84. Mylan Recent Developments/Updates
Table 85. Teva Pharmaceuticals USA Inc. Company Information
Table 86. Teva Pharmaceuticals USA Inc. Description and Business Overview
Table 87. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product
Table 89. Teva Pharmaceuticals USA Inc. Recent Developments/Updates
Table 90. Blairex Laboratories Inc. Company Information
Table 91. Blairex Laboratories Inc. Description and Business Overview
Table 92. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product
Table 94. Blairex Laboratories Inc. Recent Developments/Updates
Table 95. ARx LLC. Company Information
Table 96. ARx LLC. Description and Business Overview
Table 97. ARx LLC. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. ARx LLC. Hydrogel-based Drug Delivery Device Product
Table 99. ARx LLC. Recent Developments/Updates
Table 100. Endo International plc Company Information
Table 101. Endo International plc Description and Business Overview
Table 102. Endo International plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Endo International plc Hydrogel-based Drug Delivery Device Product
Table 104. Endo International plc Recent Developments/Updates
Table 105. BioDelivery Sciences International Inc. Company Information
Table 106. BioDelivery Sciences International Inc. Description and Business Overview
Table 107. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product
Table 109. BioDelivery Sciences International Inc. Recent Developments/Updates
Table 110. Indivior PLC Company Information
Table 111. Indivior PLC Description and Business Overview
Table 112. Indivior PLC Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Indivior PLC Hydrogel-based Drug Delivery Device Product
Table 114. Indivior PLC Recent Developments/Updates
Table 115. GSK Plc Company Information
Table 116. GSK Plc Description and Business Overview
Table 117. GSK Plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. GSK Plc Hydrogel-based Drug Delivery Device Product
Table 119. GSK Plc Recent Developments/Updates
Table 120. Pfizer Inc. Company Information
Table 121. Pfizer Inc. Description and Business Overview
Table 122. Pfizer Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Pfizer Inc. Hydrogel-based Drug Delivery Device Product
Table 124. Pfizer Inc. Recent Developments/Updates
Table 125. Aquestive Therapeutics Inc. Company Information
Table 126. Aquestive Therapeutics Inc. Description and Business Overview
Table 127. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product
Table 129. Aquestive Therapeutics Inc. Recent Developments/Updates
Table 130. ZIM LABORATORIES LIMITED Company Information
Table 131. ZIM LABORATORIES LIMITED Description and Business Overview
Table 132. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product
Table 134. ZIM LABORATORIES LIMITED Recent Developments/Updates
Table 135. IntelGenx Corp. Company Information
Table 136. IntelGenx Corp. Description and Business Overview
Table 137. IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. IntelGenx Corp. Hydrogel-based Drug Delivery Device Product
Table 139. IntelGenx Corp. Recent Developments/Updates
Table 140. NEXGEL Company Information
Table 141. NEXGEL Description and Business Overview
Table 142. NEXGEL Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. NEXGEL Hydrogel-based Drug Delivery Device Product
Table 144. NEXGEL Recent Developments/Updates
Table 145. Bliss GVS Pharma Ltd. Company Information
Table 146. Bliss GVS Pharma Ltd. Description and Business Overview
Table 147. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product
Table 149. Bliss GVS Pharma Ltd. Recent Developments/Updates
Table 150. Teika Pharmaceutical Co. Ltd. Company Information
Table 151. Teika Pharmaceutical Co. Ltd. Description and Business Overview
Table 152. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product
Table 154. Teika Pharmaceutical Co. Ltd. Recent Developments/Updates
Table 155. Medherant Limited Company Information
Table 156. Medherant Limited Description and Business Overview
Table 157. Medherant Limited Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Medherant Limited Hydrogel-based Drug Delivery Device Product
Table 159. Medherant Limited Recent Developments/Updates
Table 160. Galderma Company Information
Table 161. Galderma Description and Business Overview
Table 162. Galderma Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 163. Galderma Hydrogel-based Drug Delivery Device Product
Table 164. Galderma Recent Developments/Updates
Table 165. Johnson & Johnson Company Information
Table 166. Johnson & Johnson Description and Business Overview
Table 167. Johnson & Johnson Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 168. Johnson & Johnson Hydrogel-based Drug Delivery Device Product
Table 169. Johnson & Johnson Recent Developments/Updates
Table 170. Bausch and Lomb Company Information
Table 171. Bausch and Lomb Description and Business Overview
Table 172. Bausch and Lomb Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 173. Bausch and Lomb Hydrogel-based Drug Delivery Device Product
Table 174. Bausch and Lomb Recent Developments/Updates
Table 175. Ferring B.V Company Information
Table 176. Ferring B.V Description and Business Overview
Table 177. Ferring B.V Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 178. Ferring B.V Hydrogel-based Drug Delivery Device Product
Table 179. Ferring B.V Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Hydrogel-based Drug Delivery Device Distributors List
Table 183. Hydrogel-based Drug Delivery Device Customers List
Table 184. Hydrogel-based Drug Delivery Device Market Trends
Table 185. Hydrogel-based Drug Delivery Device Market Drivers
Table 186. Hydrogel-based Drug Delivery Device Market Challenges
Table 187. Hydrogel-based Drug Delivery Device Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Hydrogel-based Drug Delivery Device
Figure 2. Global Hydrogel-based Drug Delivery Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hydrogel-based Drug Delivery Device Market Share by Type: 2023 & 2030
Figure 4. Oral Product Picture
Figure 5. Buccal Product Picture
Figure 6. Rectal Product Picture
Figure 7. Vaginal Product Picture
Figure 8. Other Product Picture
Figure 9. Global Hydrogel-based Drug Delivery Device Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Hydrogel-based Drug Delivery Device Market Share by Application: 2023 & 2030
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Other
Figure 14. Global Hydrogel-based Drug Delivery Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Hydrogel-based Drug Delivery Device Market Size (2019-2030) & (US$ Million)
Figure 16. Global Hydrogel-based Drug Delivery Device Sales (2019-2030) & (K Units)
Figure 17. Global Hydrogel-based Drug Delivery Device Average Price (US$/Unit) & (2019-2030)
Figure 18. Hydrogel-based Drug Delivery Device Report Years Considered
Figure 19. Hydrogel-based Drug Delivery Device Sales Share by Manufacturers in 2023
Figure 20. Global Hydrogel-based Drug Delivery Device Revenue Share by Manufacturers in 2023
Figure 21. Global 5 and 10 Largest Hydrogel-based Drug Delivery Device Players: Market Share by Revenue in Hydrogel-based Drug Delivery Device in 2023
Figure 22. Hydrogel-based Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 23. Global Hydrogel-based Drug Delivery Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Hydrogel-based Drug Delivery Device Sales Market Share by Country (2019-2030)
Figure 25. North America Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2019-2030)
Figure 26. United States Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Hydrogel-based Drug Delivery Device Sales Market Share by Country (2019-2030)
Figure 29. Europe Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2019-2030)
Figure 30. Germany Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Hydrogel-based Drug Delivery Device Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Hydrogel-based Drug Delivery Device Revenue Market Share by Region (2019-2030)
Figure 37. China Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Hydrogel-based Drug Delivery Device Sales Market Share by Country (2019-2030)
Figure 45. Mexico Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Colombia Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East and Africa Hydrogel-based Drug Delivery Device Sales Market Share by Country (2019-2030)
Figure 50. Middle East and Africa Hydrogel-based Drug Delivery Device Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Hydrogel-based Drug Delivery Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Hydrogel-based Drug Delivery Device by Type (2019-2030)
Figure 55. Global Revenue Market Share of Hydrogel-based Drug Delivery Device by Type (2019-2030)
Figure 56. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Hydrogel-based Drug Delivery Device by Application (2019-2030)
Figure 58. Global Revenue Market Share of Hydrogel-based Drug Delivery Device by Application (2019-2030)
Figure 59. Global Hydrogel-based Drug Delivery Device Price (US$/Unit) by Application (2019-2030)
Figure 60. Hydrogel-based Drug Delivery Device Value Chain
Figure 61. Hydrogel-based Drug Delivery Device Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Hydrogel-based Drug Delivery Device market?
The top companies in the global Hydrogel-based Drug Delivery Device market are AstraZeneca Plc.、Columbia Laboratories Inc.、Mylan.
Related Reports
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 198
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 119
USD 4250.00
(Single User License)
Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 153
USD 3950.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 140
USD 2900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 197
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 117
USD 4250.00
(Single User License)
Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 168
USD 3950.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 112
USD 2900.00
(Single User License)
Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 179
USD 4350.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 192
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 198
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 119
USD 4250.00 (Single User License)Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 153
USD 3950.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 140
USD 2900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 197
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 117
USD 4250.00 (Single User License)Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 168
USD 3950.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 112
USD 2900.00 (Single User License)Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 179
USD 4350.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 192
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now